Click Therapeutics, Inc. — SEC Form D Filing

Click Therapeutics, Inc. filed an SEC Form D on October 1, 2026, reporting $50.00M raised in Other Health Care.

Form D filing details

Filing
SEC Form D
Filing date
October 1, 2026
Amount reported
$50.00M
Round stage
Growth because raising approximately $50 million in equity indicates a mature, clinical-stage company scaling its commercial partnerships and FDA clearance pipeline.
Industry
Other Health Care
Website
https://www.clicktherapeutics.com

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Patients suffering from chronic psychiatric and neurological conditions lack accessible, clinically validated, and non-invasive treatment options to supplement traditional pharmaceutical therapies.

Solution

Click Therapeutics develops and commercializes FDA-regulated prescription digital therapeutics delivered through mobile applications that utilize cognitive, behavioral, and neuromodulatory approaches to treat medical conditions.

Why now

The convergence of widespread smartphone adoption, established regulatory pathways for software-as-a-medical-device, and increasing clinical acceptance of digital health interventions has created a massive opportunity for prescription software.

Source: SEC EDGAR Form D filing